In the current market crisis, biotech IPOs and financing are down, but partnering continues, and M&As are as hot as ever.
Jun 1, 2008
By:
G. Steven Burrill
|
Following the market crisis of the first quarter of 2008, biotech IPOs and financing are down, but partnering continues, and mergers and acquisitions (M&As) remain hot.  Mar 1, 2008
By:
G. Steven Burrill
|
Despite the rising fears about a slowing economy, the biotech industry will continue to maintain its momentum this year.
| 
